HLA-C*18:01 and KIR2DL2+C1 genetic variants are associated with low viral load in cART naïve HIV-infected adult Zimbabweans.
暂无分享,去创建一个
S. Rowland-Jones | B. Stray-Pedersen | C. Musarurwa | L. Zijenah | C. Dandara | D. Mhandire | K. Duri | H. Matarira | K. Mhandire | M. Tshabalala | Tommy Mlambo | Kerina Duri
[1] M. Carrington,et al. Host genetic variation and HIV disease: from mapping to mechanism , 2017, Immunogenetics.
[2] B. Stray-Pedersen,et al. Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection , 2017, The open AIDS journal.
[3] S. Rowland-Jones,et al. KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection? , 2016, Omics : a journal of integrative biology.
[4] M. Carrington,et al. HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03. , 2016, Cell reports.
[5] L. Kestens,et al. The role of NK cells in HIV-1 protection: autologous, allogeneic or both? , 2016, AIDS Research and Therapy.
[6] M. Altfeld,et al. Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women , 2015, BMC Infectious Diseases.
[7] S. Rowland-Jones,et al. HLA Correlates of Long-Term Survival in Vertically Infected HIV-1-Positive Adolescents in Harare, Zimbabwe , 2015, AIDS research and human retroviruses.
[8] Lisa P. Barrett,et al. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells , 2014, Immunology and cell biology.
[9] M. Altfeld,et al. Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03: 04 and modulate primary natural killer cell function , 2014, AIDS.
[10] L. Kuhn,et al. KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission. , 2013, Clinical immunology.
[11] Bin Zhao,et al. KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors , 2013, BMC Infectious Diseases.
[12] M. Carrington,et al. Immunogenetics of HIV disease , 2013, Immunological reviews.
[13] P. Parham,et al. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3 , 2012, Front. Immun..
[14] M. Altfeld,et al. HLA-Cw*0102-Restricted HIV-1 p24 Epitope Variants Can Modulate the Binding of the Inhibitory KIR2DL2 Receptor and Primary NK Cell Function , 2012, Retrovirology.
[15] K. Collins,et al. The emerging role of HLA‐C in HIV‐1 infection , 2011, Immunology.
[16] E. Netto,et al. HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[17] A. Telenti,et al. Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression , 2010, PloS one.
[18] D. Ge,et al. HLA-C cell surface expression and control of HIV / AIDS correlate with a variant upstream of HLA-C , 2009 .
[19] M. Carrington,et al. KIR-HLA intercourse in HIV disease. , 2008, Trends in microbiology.
[20] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[21] J. Goedert,et al. KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections , 2006, PLoS pathogens.
[22] E. Karita,et al. Human Leukocyte Antigen B58 Supertype and Human Immunodeficiency Virus Type 1 Infection in Native Africans , 2006, Journal of Virology.
[23] J. Goedert,et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis , 2005, Nature Medicine.
[24] Sarah Rowland-Jones,et al. Structures of Three HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Nonprogression12 , 2005, The Journal of Immunology.
[25] Bette Korber,et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.
[26] S. Osmanov,et al. HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians. , 2004, Human immunology.
[27] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[28] S O'Brien,et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.
[29] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[30] Eric O Long,et al. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. , 1995, Immunity.
[31] Jerzy K. Kulski,et al. The HLA genomic loci map: expression, interaction, diversity and disease , 2009, Journal of Human Genetics.
[32] S. Ogawa,et al. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[33] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.